Trial Details

Not Recruiting
Basic Information
Clinical ID c5058
Identifier EUCTR2022-000837-17-NL
Trial Title Subcutaneous vedolizumab drug de-escalation using therapeutic drug monitoring in inflammatory bowel disease: a randomized controlled pilot study - SILVER-study
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Inflammatory bowel diseases (Crohn's disease, ulcerative colitis);Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Trade Name: Vedolizumab, Entyvio Pharmaceutical Form: Injection
Participant Information
Sponsor Amsterdam UMC
City NULL
Country/Region Netherlands
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE4
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL